← Eichor
Study identifier: NCT06526325 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Tendon Release Techniques in Patients With Cervical Disc Herniation

Condition: Cervical Disc Herniation  ·  Sponsor: Istanbul Arel University

PhaseNA
Planned participants51
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to investigate the effect of using enhanced golgi tendon organ stimulation on symptoms in patients with cervical disc herniation. The main question\[s\] it aims to answer are: * Enhanced Golgi tendon organ stimulation is effective in reducing symptoms in patients with cervical disc herniation. * Enhanced golgi tendon organ stimulation is not effective in reducing symptoms in patients with cervical disc herniation. Participants will receive enhanced golgi tendon organ stimulation to the Sternocleidomastoideus, platysma, longus colli, longus capitis, scalene, rhomboid major \& minor, levator scapulae and trapezius muscles for 3 weeks, 2 sessions per week for 45 minutes.

This description comes directly from the study's public registry record.

Talk to the study team

hasan aslan  ·  +905538073527  ·  asfizyoterapi@gmail.com

mehmet aslan  ·  +905521873527  ·  sharisin.aslan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

AS Physiotherapy Services centreIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06526325